P3 Health PartnersvsThermo Fisher Scientific

PIII and TMO stock compared: price, dividend, valuation and results, from SEC filings.

PIII

P3 Health Partners Inc.

$2.41

Value $7.9M

-10.74%
PIII's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

P3 Health Partners (PIII) has a market value of $7.9M and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, PIII moved -64.8% and TMO +19.9%. Dividend yield: PIII none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    PIII$7.9M

    TMO$257B

    TMO is 32,598 times PIII

  • Revenue, 12 months

    PIII$1.6B

    TMO$47.4B

    TMO is 30 times PIII

  • Net income, 12 months

    PIII-$51M

    TMO$7.1B

  • Operating margin

    PIII-5.2%

    TMO17.9%

    23.1 points apart

  • ROIC

    PIII-34.0%

    TMO8.2%

    42.2 points apart

  • P/E

    PIII–

    TMO36.3

  • Dividend yield

    PIII0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    PIII-99.5%

    TMO+10.9%

    110.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

PIII-99.5%

TMO+10.9%

05010020222023202420252026
Returns by period
PeriodPIIIWith dividendsTMOWith dividends
1 year since November 14, 2025-64.8%Price -64.8%+19.9%Price +19.5%
3 years since November 16, 2023-95.9%-65.6% a yearPrice -95.9%+47.7%+13.9% a yearPrice +46.3%
5 years since November 15, 2021-99.5%-65.6% a yearPrice -99.5%+10.9%+2.1% a yearPrice +9.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

PIIIP3 Health PartnersTMOThermo Fisher Scientific

Valuation

PIIITMO
Valuation
Price$2.41$691.33
Market value$7.9M$257B
Enterprise value (EV)$86M$292B
P/E–36.3
P/E, 5-year median–32.7
P/B0.14.7
EV/EBIT–34.5
Free cash flow yield–3.0%

Results and growth

PIIITMO
Results and growth
Revenue, 12 months$1.6B$47.4B
Net income, 12 months-$51M$7.1B
Free cash flow, 12 months-$116M$7.6B
Earnings per share, 12 months-$23.32$18.96
Revenue growth, year on year-2.8%3.9%
Revenue growth a year, past+24.3%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

PIIITMO
Margins and returns on capital
Gross margin––
Operating margin-5.2%17.9%
Net margin-3.3%14.9%
ROIC-34.0%8.2%
ROE–13.4%

Balance sheet

PIIITMO
Balance sheet
Cash$44M$6.1B
Total debt$132M$41.4B
Net debt / EBITDA28.53.7
Interest cover–5.5×

Dividends and buybacks

PIIITMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: PIII or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, P3 Health Partners or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 32,598.2 times P3 Health Partners ($7.9M), at today's prices.

How did PIII and TMO stock do over the last 5 years?

Since November 15, 2021, PIII's price moved -99.5% and TMO's +9.3%. With dividends: PIII -99.5% (-65.6% a year), TMO +10.9% (+2.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, PIII or TMO?

The dividend yield at today's price is none for P3 Health Partners and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, P3 Health Partners or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -3.3% for P3 Health Partners and 14.9% for Thermo Fisher Scientific, and the operating margin -5.2% and 17.9%. Revenue was $1.6B and $47.4B.

Which is the better investment, P3 Health Partners or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.